1.
Becattini C, Bauersachs R, Maraziti G, Bertoletti L, Cohen A, Connors JM, Manfellotto D, Sanchez A, Brenner B, Agnelli G. Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial. haematol [Internet]. 2021Aug.12 [cited 2021Oct.26];. Available from: https://haematologica.org/article/view/haematol.2021.279072